Zephyrnet Logo

Tag: Inc.

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against...

ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software | BioSpace

The clinician-driven design of the precision system is the foundation of ICU Medical's long-term IV systems product road map that seeks to blend ease...

NaaS Technology Plans to Acquire Charge Amps for US$66.4M to Collaborate on EV Charging Innovations and Energy Sustainability

On Aug. 22, NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS"), a leading EV charging solution provider listed on Nasdaq since June 13, 2022, has announced...

Valasys Media LLP Ranks No. 2732 on the 2023 Inc. 5000 as America’s Fastest Growing Private Company

"Valasys Media makes it into the Inc.5000 for the class of 2023 as America's Fastest Growing Private Company with #33 as industry rank...

Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023 | BioSpace

REDWOOD CITY, CA / ACCESSWIRE / August 24, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular...

The 5 Largest Microchip Companies in the World

In the fast-paced world of technology, microchips are the unsung heroes that power our devices, from smartphones to self-driving cars. The five largest microchip...

First Patient Dosed in Phase 3 Trial of Ivonescimab versus Tislelizumab for First-line Treatment of Squamous NSCLC – Drugs.com MedNews

HONG KONG, Aug. 18, 2023. Akeso Inc. ("Akeso", 9926. HK) announced today that the first patient has been dosed in a head-to-head phase III...

FDA Approves Veopoz (pozelimab-bbfg) as the First Treatment for Children and Adults with CHAPLE Disease

FDA Approves Veopoz (pozelimab-bbfg) as the First Treatment for Children and Adults with CHAPLE DiseaseTARRYTOWN, N.Y., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,...

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with...

PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application | BioSpace

MINNEAPOLIS, MN, Aug. 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company") an emerging biomedical device company focused on...

Catalyst Clinical Research Named to Inc. 5000 List of Fastest-Growing Private Companies for Fourth Consecutive Year – Catalyst Clinical Research

The company ranked in the top half of the Inc. 5000 list with approximately a 202% increase in revenue from the previous period and...

Hertz Lithium Acquires Option to Acquire Patriota Lithium Project in the Aracuai Pegmatite District

HIGHLIGHTS: Hertz has entered into an assignment agreement pursuant to which it has acquired the option to acquire the prospective Patriota Lithium Project in...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?